Biomarker detection shows competitive sensitivity in neurological disorders using a scalable biosensor with Bayesian regression.
This paper presents a designed metasurface sensor for protein biomarkers detection. The design of this metasurface structure is essentially dependent on the coating of four identical figure-eight-shaped resonators of MXene through black phosphorus and graphene. Meanwhile, the performance analysis demonstrates a competitive sensitivity (395 GHz/RIU) with a linear frequency response of R² = 0.954 and protein biomarker concentration (R² = 0.956). The sensor exhibits stable performance across 0.31-0.46 THz and maintains consistent operation at incident angles up to 30°. Interestingly, this tunability is achieved through graphene chemical potential modulation, with transmittance decreasing from 97.7% to 66.7% as its value increases. Additionally, the machine learning optimization using Bayesian Ridge Regression demonstrates exceptional predictive capabilities for both refractive index variations (R² ≈ 86%) and angular dependencies (R² ≈ 96%). This integrated photonic-microfluidic sensor platform offers significant potential for early detection of neurological disorders through rapid, sensitive, and scalable brain tumor biomarker analysis.
No takes yet. Share an insight, caveat, or question.
Ahmed et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: